Be ready to pounce on homebuilding stocks the next time they drop, Jim Cramer says

Be ready to pounce on homebuilding stocks the next time they drop, Jim Cramer says


CNBC’s Jim Cramer said Thursday that despite conventional wisdom, he believes investors should pick up shares of homebuilding stocks the next time they plummet.

“I believe these stocks will drop again, but when they do — and that might be on a statement from the Fed that says they’re still seeing signs of inflation — I think you’ve got to pounce,” the “Mad Money” host said. “That could be as soon as the next rate hike.”

Homebuilder sentiment fell to a two-year low on decreasing demand and rising costs in May. Mortgage rates rose sharply this week after easing over the last few weeks, as home prices also continued to rise.

But Cramer says there are bullish signs for the market suggesting that despite the Federal Reserve getting ready to tighten the economy, homebuilding stocks might go against the tide and be attractive assets for investors’ portfolios.

He pointed out that the pandemic has changed the homebuilding industry’s landscape, leaving downtown offices empty because of work-from-home, plumping potential buyers’ bank accounts and driving a baby boom that could mean more business for homebuilding companies.

In addition, skyrocketing rent prices have meant some people invested in homes rather than signing a lease, while constrained supplies of houses have kept properties from depreciating in value and led to bidding wars between potential buyers, he said.

“We’ll get more downgrades and maybe even some estimate cuts, but when they come I’m going to go out on a limb right here and I’m going to say the time is right to buy the homebuilders,” Cramer said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More
Lawyers to the wealthy warn that AI legal advice comes with serious risks
Business

Lawyers to the wealthy warn that AI legal advice comes with serious risks

Displeased couple having problems during a meeting with their agent in the office. Skynesher | E+ | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Lawyer Tasha Dickinson said […]

Read More
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Business

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IMF) and World Bank Spring meetings in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past […]

Read More